Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 26954325.
- Also identified by DOI 10.1371/journal.pmed.1001970 and PMC identifier 4783061.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Brook Baker describes the potential harms to global health from the Trans Pacific Partnership Agreement and its failure to balance the interests of patients and the public with those of industry.
Medical subject headings
- Drug Industry
- Drugs, Generic
- Intellectual Property
- International Cooperation
- Investments